International students wishing to pursue a graduate degree at the Macquarie University Centre for the Health Economy are invited to apply for a full scholarship.
Macquarie University and the Macquarie University Centre for the Health Economy (MUCHE) have partnered with five pharmaceutical companies to develop a unique and innovative higher degree research programme, the first of its kind in Australia.
These partners include Amgen Australia, Janssen Australia, MSD Australia, Pfizer Australia, and Roche Australia.
The programme is aimed at students willing to undertake research relevant to the Australian pharmaceutical sector and government.
While research questions will be determined by the student and their supervisor, students can also draw on outcomes from an annual pharmaceutical sector research workshop.
The scholarship offers a stipend and tuition fee offset.
The deadline is on Friday 31st December 2021.
This scholarship is available to eligible candidates to undertake either the MRes Year 2 + PhD or direct entry PhD.
To be eligible for a scholarship, applicants are expected to have a record of excellent academic performance and, preferably, additional relevant research experience and/or peer-reviewed research activity in line with the University’s scholarship rating guidelines.
Find out more now.
From Australia to Denmark, with this next opportunity:
Share this post
Interested in co-operating with us?
We are open to co-operation from writers and businesses alike. You can reach us on our email at email@example.com and we will get back to you as quick as we can.